Ausgabe 4/2014
Inhalt (15 Artikel)
Chronic Myelomonocytic Leukemia Prognostic Classification and Management: Evidence Base and Current Practice
- Myeloproliferative Disorders (C Harrison, Section Editor)
Dorothée Selimoglu-Buet, Eric Solary
Back to Biology: New Insights on Inheritance in Myeloproliferative Disorders
- Myeloproliferative Disorders (C Harrison, Section Editor)
Evan M. Braunstein, Alison R. Moliterno
Antiplatelet Therapy in the Management of Myeloproliferative Neoplasms
- Myeloproliferative Disorders (C Harrison, Section Editor)
Alberto Alvarez-Larrán, Carlos Besses
Quality of Life in MPN Comes of Age as a Therapeutic Target
- Myeloproliferative Disorders (C Harrison, Section Editor)
Robyn M. Scherber, Holly L. Geyer, Ruben A. Mesa
An Immune Dysregulation in MPN
- Myeloproliferative Disorders (C Harrison, Section Editor)
Giovanni Barosi
Epidemiology of MPN: What Do We Know?
- Myeloproliferative Disorders (C Harrison, Section Editor)
L. A. Anderson, M. F. McMullin
Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
- Open Access
- Myeloproliferative Disorders (C Harrison, Section Editor)
A. Yacoub, O. Odenike, S. Verstovsek
Controversies in Multiple Myeloma: to Transplant or Not?
- Multiple Myeloma (R Niesvizky, Section Editor)
Isabel Ruth Preeshagul, Koen Van Besien, Tomer M. Mark
Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
- Multiple Myeloma (R Niesvizky, Section Editor)
Noa Biran, Scott Ely, Ajai Chari
What We Mean When We Talk About MRD in Myeloma. A Review of Current Methods. Part 1 of a Two-Part Series
- Multiple Myeloma (R Niesvizky, Section Editor)
Scott Ely, Noa Biran, Ajai Chari
I Walk the Line: How to Tell MDS From Other Bone Marrow Failure Conditions
- Myelodysplastic Syndromes (M Sekeres, Section Editor)
Lukasz P. Gondek, Amy E. DeZern
I Walk the Other Line: Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndromes
- Myelodysplastic Syndromes (M Sekeres, Section Editor)
Aaron T. Gerds
Lessons from the Atomic Bomb About Secondary MDS
- Myelodysplastic Syndromes (M Sekeres, Section Editor)
Tomoko Hata, Daisuke Imanishi, Yasushi Miyazaki
Resuscitating a Dying Marrow: the Role of Hematopoietic Growth Factors
- Myelodysplastic Syndromes (M Sekeres, Section Editor)
Aakriti Pandita, Sudipto Mukherjee
Stopping Higher-Risk Myelodysplastic Syndrome in Its Tracks
- Myelodsyplastic Syndromes (M Sekeres, Section Editor)
Daniel A. Pollyea, Jonathan A. Gutman
